Skip to content

IPACK Block After Total Knee Arthroplasty

Comparison of Adductor Canal Block and IPACK Block With Adductor Canal Block Alone After Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04295421
Enrollment
88
Registered
2020-03-04
Start date
2020-03-31
Completion date
2022-07-31
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthropathy, Postoperative Pain

Keywords

knee arthoplasty, nerve block, analgesia

Brief summary

Adductor canal block (ACB) is a peripheral nerve blockade technique that provides good pain control in patients undergoing total knee arthroplasty (TKA) which however does not relieve posterior knee pain. The recent technique of an ultrasound-guided local anesthetic infiltration of the interspace between popliteal artery and the capsule of posterior knee (IPACK) has shown promising results in providing significant posterior knee analgesia without affecting the motor nerves. The hypothesis was that the combination of ACB + IPACK will provide better pain relief and improve knee function in the immediate postoperative period compared to ACB alone.

Detailed description

This is a prospective, randomized and double blinded study All patients received : * Pregabalin 150 mg preoperatively 12 h before the surgery. * Single-shot spinal anesthesia with 10 to 12 mg of bupivacaine 0.5% and 2.5ug sufentanil patients were randomly allocated to receive: * Group 1: IPACK + ACB single shoot * Group 2: contineous ACB For group 1: IPACK was realized after spinal anesthesia with 40 ml ropivacaine 0.2% All patients received ACB in the immediate postoperative period with 20 ml ropivacaine 0.2% Post operative analgesia included: * Paracetamol 1g IV every 6 hours * Diclofenac sodium (50mg) 1 tablet x 2 per day * Pregabalin 150 mg given orally once daily for a period of 4 weeks. * PCA morphine (Patient Controlled Analgesia), as a rescue analgesia, * Continuous ACB catheter for 48H with : 4 ml per hour 0.2% ropivacaine in group 2 4 ml per hour saline in group 1

Interventions

PROCEDUREadductor canal block

ACB was done in the immediate postoperative period under a high-frequency ultrasound guidance in which the adductor canal was identified beneath the sartorius muscle and 20 ml of 0.2% ropivacaine was injected in the canal using a 22-gauge 100-mm short-beveled regional block needle and a catheter was kept for 48H with 4 ml/h ropivacaine 0.2%.

PROCEDUREIPACK block

IPACK block was realized after spinal anesthesia with 40 ml 0.2% ropivacaine and at the end of surgery , patients were given ACB with 20 ml 0.2% ropivacaine and continued with 4 ml/H saline for 48H

Sponsors

Institut Kassab d'Orthopédie
CollaboratorOTHER
University Tunis El Manar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* primary total knee arthroplasty under spinal anesthesia

Exclusion criteria

* Contraindication or refusal to regional anesthesia * Contraindication to non steroidal anti inflammatory (NSAID's) * Allergy to opioids * Allergy to paracetamol * Creatinine clearance \< 30ml/min * Weight\<50 kg or \>100kg

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumptionDay 2total Morphine consumption

Secondary

MeasureTime frameDescription
Pain score at restDay 2numerical rating scale \[0=no pain ; 10=worste pain\]
Pain score during mouvmentDay 2 [0=no pain ; 10=worste pain]numerical rating scale
Ambulation distanceDay 2number of steps walked by the patient
Chronic painMonth 6DN4 score \[0=minimum to 10= worste score\]
functional statusMonth 6KOOS PS score \[0=minimum to 28= worste score\]

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026